*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE 150MG/200MG/300MG TABLETS

Lamivudine; Nevirapine; Zidovudine
150 mg; 200 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Healthline Limited

NRN

A4-2813

Status

Active


ATC Code

J05AR05  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE 150MG/200MG/300MG TABLETS A4-2813 LAMIVUDINE/NEVIRAPINE/ZIDOVUDINE 150MG/200MG/300MG TABLETS ACTIVE INGREDIENTS:EACH FILM–COATED TABLET CONTAINS 150 MG OF LAMIVUDINE, 200 MG OF NEVIRAPINE AND 300 MG OF ZIDOVUDINE. INACTIVE INGREDIENTS:MICROCRYSTALLINE CELLULOSE 398.00MG, LACTOSE MONOHYDRATE 100.00MG, SODIUM STARCH GLYCOLATE 12.00MG, MAGNESIUM STEARATE 12.00MG, PROVIDONE K30 - 16.00MG Prescription Only Medicine (POM) HEALTHLINE LIMITED, 29,ADENIYI JONES IKEJA LAGOS MYLAN LABORATORIES LIMITED (MLL), PLOT NO. H-12&H-13, MIDC, WALUJ, AURANGABAD 431136, MAHARASHTRA STATE, INDIA, India 2/23/2023 2/22/2028

Manufacturer Name

Mylan Laboratories Limited

Manufacturer Country

INDIA  

Approval Date

2023-02-23  

Expiry Date

2028-02-22